摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-isothiocyanato-1-methylethyl)phenol

中文名称
——
中文别名
——
英文名称
4-(2-isothiocyanato-1-methylethyl)phenol
英文别名
2-(4-hydroxy-phenyl)-propyl isothiocyanate;2-(4-Hydroxy-phenyl)-propylisothiocyanat;4-(β-Isothiocyanato-isopropyl)-phenol;4-(1-Isothiocyanatopropan-2-yl)phenol
4-(2-isothiocyanato-1-methylethyl)phenol化学式
CAS
——
化学式
C10H11NOS
mdl
——
分子量
193.269
InChiKey
WTDFRIJJYCZRLG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    64.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor
    摘要:
    Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has roles in the innate immune response, and also contributes to inflammatory disease. While the biological properties of MIF are closely linked to protein protein interactions, MW also has tautomerase activity. Inhibition of this activity interferes with the interaction of MIF with protein partners e.g. the CD74 receptor, and tautomerase inhibitors show promise in disease models including multiple sclerosis and colitis. Isothiocyanates inhibit MIF tautomerase activity via covalent modification of the N-terminal proline. We systematically explored variants of benzyl and phenethyl isothiocyanates, to define determinants of inhibition. In particular, substitution with hydroxyl, chloro, fluoro and trifluoro moieties at the para and meta positions were evaluated. In assays on treated cells and recombinant protein, the IC50 varied from 250 nM to >100 mu M. X-ray crystal structures of selected complexes revealed that two binding modes are accessed by some compounds, perhaps owing to strain in short linkers between the isothiocyanate and aromatic ring. The variety of binding modes confirms the existence of two subsites for inhibitors and establishes a platform for the development of potent inhibitors of MIF that only need to target one of these subsites. (C) 2015 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2015.02.012
点击查看最新优质反应信息

文献信息

  • Thiazolinephenols. 5-Methyl- and 5,5-Dimethylthiazolinephenols, By-Products and Derivatives
    作者:William F. Hart、Joseph B. Niederl
    DOI:10.1021/ja01874a041
    日期:1939.5
  • Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor
    作者:Emma S. Spencer、Edward J. Dale、Aimée L. Gommans、Malcolm T. Rutledge、Christine T. Vo、Yoshio Nakatani、Allan B. Gamble、Robin A.J. Smith、Sigurd M. Wilbanks、Mark B. Hampton、Joel D.A. Tyndall
    DOI:10.1016/j.ejmech.2015.02.012
    日期:2015.3
    Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has roles in the innate immune response, and also contributes to inflammatory disease. While the biological properties of MIF are closely linked to protein protein interactions, MW also has tautomerase activity. Inhibition of this activity interferes with the interaction of MIF with protein partners e.g. the CD74 receptor, and tautomerase inhibitors show promise in disease models including multiple sclerosis and colitis. Isothiocyanates inhibit MIF tautomerase activity via covalent modification of the N-terminal proline. We systematically explored variants of benzyl and phenethyl isothiocyanates, to define determinants of inhibition. In particular, substitution with hydroxyl, chloro, fluoro and trifluoro moieties at the para and meta positions were evaluated. In assays on treated cells and recombinant protein, the IC50 varied from 250 nM to >100 mu M. X-ray crystal structures of selected complexes revealed that two binding modes are accessed by some compounds, perhaps owing to strain in short linkers between the isothiocyanate and aromatic ring. The variety of binding modes confirms the existence of two subsites for inhibitors and establishes a platform for the development of potent inhibitors of MIF that only need to target one of these subsites. (C) 2015 Elsevier Masson SAS. All rights reserved.
查看更多